Baxter obtains FDA authorization for Oxiris blood purification filter for COVID-19 treatment

July 14, 2020

On 10 April 2020, the US Food and Drug Administration (FDA) issued an emergency use authorization for the blood purification system for the treatment of patients with confirmed Coronavirus disease (COVID-19) aged 18 or older admitted to the intensive care units (ICU) with confirmed or expected respiratory failure.

With this type of treatment and filter (which we now also use in patients with severe Covid -19 infection), our hospital has excellent experience since 2008 in the treatment of patients with severe viral and bacterial diseases, and also in patients with systemic inflammatory response, a condition that is common and a serious complication in cardiac surgery patients.

Blood Purification Devices EUAs

Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment

Oxiris Info